BPC-157 Research for Tendonitis
An evidence-based overview of research examining BPC-157 in the context of tendonitis. This page synthesizes findings from peer-reviewed literature.
Research Summary
BPC-157 has been studied for its potential effects on tendon healing in preclinical models. Research from Taiwanese laboratories demonstrated that BPC-157 promotes tendon fibroblast proliferation and migration through FAK-paxillin pathway activation (Chang et al., 2011). However, all available evidence is preclinical. No human clinical trials have evaluated BPC-157 for tendonitis.
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. BPC-157 has not received regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.